(Q74034489)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10905591%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Antigen-specific immunotherapy for human papillomavirus 16 E7-expressing tumors grown in the liver (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10905591%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

main subject

human papillomavirus 16

1 reference

1 reference

C H Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10905591%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

K W Suh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10905591%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

H Ji

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10905591%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M A Choti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10905591%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

D M Pardoll

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10905591%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

T C Wu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10905591%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10905591%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10905591%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10905591%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10905591%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

91-98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10905591%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

1 reference

7 January 2021

A new era for cancer immunotherapy based on the genes that encode cancer antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

T cell defined tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Cancer vaccines based on the identification of genes encoding cancer regression antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

The role of CD4+ T cell responses in antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Identification of two lysosomal membrane glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Modulation of tumor cell response to chemotherapy by the organ environment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Quantification of antigen specific CD8+ T cells using an ELISPOT assay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

A sensitive ELISPOT assay to detect low-frequency human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Hepatocellular carcinoma: Recent progress

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Gene therapy of liver tumors: principles and applications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Gene therapy for hepatocellular carcinoma: progress but many stones yet unturned!

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Gene therapy for hepatic micrometastasis of murine colon carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor alpha gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma: implication for immunotherapy of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Vaccination with dendritic cells inhibits the growth of hepatic metastases in B6 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Effective tumor vaccines generated by in vitro modification of tumor cells with cytokines and bispecific monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Expression of Fas ligand in liver metastases of human colonic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Prospects for adoptive T cell therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980164-6

7 January 2021

10.1016/S0168-8278(00)80164-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10905591%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference